© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 13, 1065-1073,
July 5, 2000
© 2000 Oxford University Press
Focal Adhesion Kinase, Rap1, and Transcriptional Induction of Vascular Endothelial Growth Factor
Affiliations of authors: E. A. Sheta, M. A. Harding, D. Theodorescu (Department of Molecular Physiology and Biological Physics), M. R. Conaway (Department of Health Evaluation Sciences), University of Virginia Health Sciences Center, Charlottesville.
Correspondence to: Dan Theodorescu, M.D., Ph.D., Box 422, University of Virginia Health Sciences Center, Charlottesville, VA 22908 (e-mail: Theodorescu{at}virginia.edu).
Background: Signals from a cell's environment are sensed by receptors, which activate pathways that, in turn, transmit the signals to the nucleus, informing decisions on growth, angiogenesis, and other cell functions. Transcription of vascular endothelial growth factor (VEGF), a potent angiogenic factor, can be induced by cell–cell contact. In the current work, we sought to determine if this induction is dependent on transformation of cells to a malignant phenotype and subsequently to determine which signaling molecules mediate activation of VEGF transcription. Methods: Normal and transformed prostate epithelial cell lines were examined at various cell densities to simulate the effect of increased cell contact on expression of VEGF messenger RNA. Transformed cells were also cotransfected with a VEGF promoter-reporter construct and with constructs that express dominant negative or activated versions of signal transduction proteins hypothesized to be involved in the cell–cell contact process, and reporter activity was assessed at various cell densities. All P values are two-sided. Results: Direct cell–cell contact, but not extracellular matrix components, resulted in transcriptional activation of a VEGF promoter-reporter construct in malignant (P<.0001) but not in nonmalignant (P = .37) prostate cells. This process was mediated via a mitogen-activated protein kinase (MAPK); it required the activity of focal adhesion kinase (FAK), Rap1, and Raf and was Ras independent. In addition, transcriptional activation of a Ras-sensitive Elk-1 chimeric reporter by cell–cell contact suggests that Rap1 is a key factor in regulating the specificity of convergent MAPK-signaling pathways arising from different upstream extracellular stimuli. Conclusions: Cell contact induction of VEGF transcription via FAK and Rap1 provides a novel Ras-independent, but transformation-dependent, mechanism for stimulus-specific regulation of tumor VEGF expression via MAPK.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Chrzanowska-Wodnicka, A. E. Kraus, D. Gale, G. C. White II, and J. VanSluys Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice Blood, March 1, 2008; 111(5): 2647 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Halder, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, T. Honda, A. A. Kamat, L. Y. Han, T. J. Kim, C. Lu, et al. Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma Cancer Res., November 15, 2007; 67(22): 10976 - 10983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Itoh, C. M. Nelson, C. A. Myers, and M. J. Bissell Rap1 Integrates Tissue Polarity, Lumen Formation, and Tumorigenic Potential in Human Breast Epithelial Cells Cancer Res., May 15, 2007; 67(10): 4759 - 4766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Halder, A. A. Kamat, C. N. Landen Jr., L. Y. Han, S. K. Lutgendorf, Y. G. Lin, W. M. Merritt, N. B. Jennings, A. Chavez-Reyes, R. L. Coleman, et al. Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy. Clin. Cancer Res., August 15, 2006; 12(16): 4916 - 4924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. S. Stork and T. J. Dillon Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions Blood, November 1, 2005; 106(9): 2952 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Woods, C. J. McGlade, and A. Guha Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells Neuro-oncol, October 1, 2002; 4(4): 242 - 252. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Zhang, M. Bewick, and R. M. Lafrenie Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase Carcinogenesis, July 1, 2002; 23(7): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Ellis and G. E. Gallick Promiscuous Transcription of Vascular Endothelial Growth Factor and Survival of Tumors J Natl Cancer Inst, July 5, 2000; 92(13): 1030 - 1031. [Full Text] [PDF]
|
|